Evidence map›Paper›PMID 30052529›Full record

ArticleAnesthesiology2018

Etomidate and Etomidate Analog Binding and Positive Modulation of γ-Aminobutyric Acid Type A Receptors: Evidence for a State-dependent Cutoff Effect.

Megan McGrath, Zhiyi Yu, Selwyn S Jayakar, Celena Ma, Mansi Tolia, Xiaojuan Zhou, Keith W Miller, Jonathan B Cohen, Douglas E Raines

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. GABADrug design, development and therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Megan McGrathFrom the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts (M.M., C.M., M.T., X.Z., K.W.M., D.E.R.) the Department of Neurobiology, Harvard Medical School, Boston, Massachusetts (Z.Y., S.S.J., J.B.C.).
Zhiyi Yu
Selwyn S Jayakar
Celena Ma
Mansi Tolia
Xiaojuan Zhou
Keith W Miller
Jonathan B Cohen
Douglas E Raines
American Institute of Certified Public Accountants · US

Funding

Synthetic Chemistry CoreP01GM058448 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KEITH W · 1999 to 2018
$33.6M
Etomidate Analogues as Safer General AnestheticsR01GM087316 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI RAINES, DOUGLAS E · 2010 to 2016
$3.2M
Competitive Antagonists for General Anesthetics: A New Class of Drugs for Improving Patient Care and Advancing Scientific ResearchR01GM122806 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI RAINES, DOUGLAS E · 2017 to 2020
$1.6M
NIGMS NIH HHS P01 GM058448NIGMS NIH HHS R01 GM087316NIGMS NIH HHS R01 GM122806
6 · The paper itself

Abstract

what we already know about this topicWHAT THIS ARTICLE TELLS US THAT IS NEW:

background: Naphthalene-etomidate, an etomidate analog containing a bulky phenyl ring substituent group, possesses very low γ-aminobutyric acid type A (GABAA) receptor efficacy and acts as an anesthetic-selective competitive antagonist. Using etomidate analogs containing phenyl ring substituents groups that range in volume, we tested the hypothesis that this unusual pharmacology is caused by steric hindrance that reduces binding to the receptor's open state.

methodsThe positive modulatory potencies and efficacies of etomidate and phenyl ring-substituted etomidate analogs were electrophysiology defined in oocyte-expressed α1β3γ2L GABAA receptors. Their binding affinities to the GABAA receptor's two classes of transmembrane anesthetic binding sites were assessed from their abilities to inhibit receptor labeling by the site-selective photolabels [H]azi-etomidate and tritiated R-5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid.

resultsThe positive modulatory activities of etomidate and phenyl ring-substituted etomidate analogs progressively decreased with substituent group volume, reflecting significant decreases in both potency (P = 0.005) and efficacy (P < 0.0001). Affinity for the GABAA receptor's two β - α anesthetic binding sites similarly decreased with substituent group volume (P = 0.003), whereas affinity for the receptor's α - β/γ - β sites did not (P = 0.804). Introduction of the N265M mutation, which is located at the β - α binding sites and renders GABAA receptors etomidate-insensitive, completely abolished positive modulation by naphthalene-etomidate.

conclusionsSteric hindrance selectively reduces phenyl ring-substituted etomidate analog binding affinity to the two β - α anesthetic binding sites on the GABAA receptor's open state, suggesting that the binding pocket where etomidate's phenyl ring lies becomes smaller as the receptor isomerizes from closed to open.

Indexed as

Anesthetics, IntravenousAnimalsCell Culture TechniquesEtomidateHumansOocytesReceptors, GABAXenopusAnesthetics, IntravenousEtomidateReceptors, GABA

Identifiers

PMID30052529
PMCPMC6278829
OpenAlexW2884201985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.